Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shiva Moghadam
Observed name:
Shiva moghadam
Institutions:
Academic Center for Education, Culture and Research,
Motamed Cancer Institute
Observed institutions:
Academic Center for Education, Culture and Research,
Motamed Cancer Institute
ORCID:
0009-0003-9888-7139
Observed ORCID:
0009-0003-9888-7139
OpenAlex ID:
A5039963126
A micropillar array-based microfluidic chip for label-free separation of circulating tumor cells: The best micropillar geometry?
2022
·
Mehdi Rahmanian
, Omid Sartipzadeh Hematabad
, et al.
·
Journal of Advanced Research
·
46
PDF
Idiopathic Granulomatous Mastitis: An institutional Experience from a Referral Center
2022
·
Fateme Sari
, Nahid Raei
, et al.
·
Archives of Breast Cancer
·
4
PDF
Exploratory and confirmatory factor analysis of the Persian Version of the European Organization for Research and Treatment of Cancer Quality of Life- Breast Cancer questionnaires with 45 and 42 items: EORTC QLQ-BR45 and QLQ-BR42
2025
·
shahpar haghighat
, Zahra Omidi
, et al.
·
Journal of Breast Disease
·
1
PDF
Vacuum‐Assisted Excision and Assessing Residual Tumor Burden in Patients With Breast Cancer Following Neoadjuvant Chemotherapy (A Pilot Study)
2026
·
Hawzhin Hashemi
, Asiie Olfatbakhsh
, et al.
·
International Journal of Breast Cancer
Free fatty acids fingerprinting profile of serum from different molecular subtypes of non-metastatic breast cancer using GC-FID: a pilot study
2025
·
Shiva Moghadam
, Marzieh Shakeri
, et al.
·
Multidisciplinary Cancer Investigation
PDF
Surgical Margin Status and Local Recurrence in Breast-Conserving Surgery
2025
·
Hawzhin Hashemi
, Aseie olfatbakhsh
, et al.
·
Journal of Breast Disease
PDF
Review of: "[Case Study] Targeting the Warburg Effect with the Glucose Mutation Theory: A Case Study of a 35-Year-Old Female Treated for Stage II Triple-Positive Metastatic Breast Cancer Involving Lymph Nodes Using Glucosodiene Over a 20-Day Period."
2024
·
Shiva Moghadam
·
Qeios
PDF
Efficacy and safety of diphereline 11.25 mg, microrelin 11.25 mg, and microrelin 3.75 mg in premenopausal patients with breast cancer: a non-inferiority randomized clinical trial
2023
·
Safa Najafi
, Maryam Ansari
, et al.
·
BMC Cancer
PDF
Show more works
View as search
Works count:
8
Citation count:
51
H-index:
2
I10-index:
1
Year
Topic
Type